
|Articles|August 4, 2020
Raremark launches Xperiome Platform
Advertisement
Raremark has launched its patient-powered knowledge platform Xperiome. The Xperiome platform expands on Raremark’s vision of a world in which all rare diseases are treated by connecting everyone affected by rare diseases through shared experiences—regardless of diagnosis.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
2
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
3
FDA Approves UCB’s Kygevi for TK2 Deficiency Based on Multi-Study Clinical Program Demonstrating Significant Survival and Motor Gains
4
Designing Feasible Protocols with Real-World Data
5






.png)



.png)



.png)
.png)
